Page last updated: 2024-12-05

n-benzyl-n,n-dimethylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID7681
CHEMBL ID45591
SCHEMBL ID15900
MeSH IDM0133400

Synonyms (79)

Synonym
LS-13652
benzenemethanamine, dimethyl-
28262-13-7
n,n-dimethyl(phenyl)methanamine
n-benzyldimethylamine
nsc-5342
n,n-dimethylbenzylamine
bdma
dimethylbenzylamine
n,n-dimethyl-n-benzylamine
103-83-3
nsc5342
benzyldimethylamine
benzylamine,n-dimethyl-
wln: 1n1 & 1r
benzenemethanamine,dimethyl-
n-(phenylmethyl)dimethylamine
ccris 6693
nsc 5342
ai3-26794
araldite accelerator 062
n,n-dimethylbenzenemethanamine
einecs 203-149-1
n,n'-dimethylbenzylamine
sumine 2015
un2619
benzyl-n,n-dimethylamine
n-benzyl-n,n-dimethylamine
benzylamine, n,n-dimethyl-
benzenemethanamine, n,n-dimethyl-
n,n-dimethyl-1-phenylmethanamine
inchi=1/c9h13n/c1-10(2)8-9-6-4-3-5-7-9/h3-7h,8h2,1-2h
NCGC00090991-01
n,n-dimethylbenzylamine, >=99%
n,n-dimethylbenzylamine, for protein sequence analysis, >=99.5% (gc)
n,n-dimethyl-1-phenyl-methanamine
D0688
smr001307284
MLS002222342
benzyl-dimethyl-amine
CHEMBL45591
FT-0657620
AKOS000120578
NCGC00090991-03
NCGC00090991-02
unii-typ7axq1yj
typ7axq1yj ,
ec 203-149-1
benzyldimethylamine [un2619] [corrosive]
tox21_200719
NCGC00258273-01
tox21_113457
cas-103-83-3
dtxcid801854
dtxsid8021854 ,
SCHEMBL15900
benzenemethamine, n,n-dimethyl-
un 2619
n,n-dimethyl(phenyl)methanamine #
dabco bdma
n, n-dimethylbenzylamine
n,n-dimethyl benzyl amine
benzyldimethyl-amine
n,n,-dimethylbenzylamine
dimethyl benzyl amine
dimethyl (phenylmethyl)amine
n-benzyl dimethylamine
dimethylbenzyl amine
n,n-dimethyl-benzylamine
n,n-dimethyl benzylamine
AC-10211
J-001043
J-523270
n,n-dmethylbenzylamne
mfcd00008329
Q424966
EN300-16212
n-dimethylbenzylamine
n,n-dimethylbenzylamine(benzyldimethylamine)

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.85230.006038.004119,952.5996AID1159521; AID1159523
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.00160.001318.074339.8107AID926; AID938
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency50.11870.023723.228263.5986AID588543
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID350218Octanol-water partition coefficient, log PC of the compound2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID1134602Hexane-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID102886Michaelis-Menten constant was determined for Monoamine oxidase-B from Bovine liver; b=not a substrate1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Transformation of monoamine oxidase-B primary amine substrates into time-dependent inhibitors. Tertiary amine homologues of primary amine substrates.
AID102889Catalysis activity was calculated for Monoamine oxidase-B from Bovine liver; b=not a substrate1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Transformation of monoamine oxidase-B primary amine substrates into time-dependent inhibitors. Tertiary amine homologues of primary amine substrates.
AID350216Dissociation constant, pKa of the compound2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID1134601Hydrogen-bond basicity, pKHB of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID350220Lipophilicity, log K at pH 2 by by hydrophilic interaction chromatography using 100% water as mobile phase2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID350219Lipophilicity, log K at pH 2 by by hydrophilic interaction chromatography using 95% acetonitrile as mobile phase2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (12.00)18.7374
1990's5 (20.00)18.2507
2000's8 (32.00)29.6817
2010's4 (16.00)24.3611
2020's5 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.44 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]